Vol. 10 No. 3 (2018)

Artigos

• Cost analysis of outpatient stroke in the public system perspective

  Marcio Reis, Alfredo Chaoubah, Cláudia Helena Mármora, Graziela Liebel

  219-225

  • PDF (Português (Brasil))

• Cost per response analysis of adalimumab, etanercept, guselkumab, infliximab, ixekizumab, secukinumab and ustekinumab for the treatment of moderate to severe plaque psoriasis from the Brazilian private health care system perspective

  Cyntia Fioratti, Atanacio Valencia-Mendoza, Maria Luiza Rachid, Ricardo Rosim, Marcela Junqueira

  226-231

  • PDF (Português (Brasil))

• Project management model for clinical research

  Angelica Zanotto, Karen Ruschel, Carisi Anne Polanczyk

  232-238

  • PDF (Português (Brasil))

• Economic evaluation of the use of pre-filled syringe versus manually filled syringe paraflushing in patients with central venous cateter in the perspective of health careers

  Marcelo Gomes, Helena Romcy

  239-245

  • PDF (Português (Brasil))

• The equity challenge: factors associated with outpatient production expenditures in secondary care

  Graziela Liebel, Antonio Sá Junio, Estela Campos, Yuan-Pang Wang, Patrick Dias, Alfredo Chaoubah

  246-254

  • PDF (Português (Brasil))

• Budget impact model of subcutaneous compared with intravenous rituximab in the treatment of diffuse large B-cell and follicular CD-20+ non-Hodgkin lymphoma patients in the Brazilian private healthcare system

  Diego Kashiura, Paulo Vitor Souza, Henrique Santos, Elene Nardi, Adriano Bueno de Sá, Bárbara Santos, Marcia Alves

  255-261

  • PDF (Português (Brasil))

• Cost effectiveness analysis of plasma genotyping versus tumor genotyping in detection of advanced non-small-cell lung cancer with epidermal growth factor receptor and T790M mutation under the Brazilian private healthcare system perspective

  Marcos Santos, Marcelo Custodio, Alisson Matsuo, Giuliana Montenegro, Camila Pepe, Enzo Asano, Luiz Henrique Araujo

  262-268

  • PDF

• Budget impact model of subcutaneous compared with intravenous trastuzumab in the treatment of HER-2 positive breast cancer in the Brazilian Private Healthcare System

  Diego Kashiura, Paulo Vitor Souza, Ligia Yoshida, Sarah Danielle Garrido, Elene Nardi, Marcia Regina Alves

  269-277

  • PDF (Português (Brasil))

• Secondary health care efficiency in Portugal: a comparative study

  Alexandre Nunes, Diogo Ferreira

  278-284

  • PDF (Português (Brasil))

• Innovation in hospital management: analysis of efficiency results of an portuguese hospital in a local health unit

  Sérgio Farias, Alexandre Nunes

  285-290

  • PDF (Português (Brasil))

• Diagnostic imaging in Brazil: a system, many realities

  Graziela Liebel, Antonio Reis de Sá Junior, Estela Márcia Campos, Fabiano Loures, Patrick Dias, Alfredo Chaoubah

  291-297

  • PDF (Português (Brasil))

• Methodological choices applied to analytical models and their influence on the results of economic evaluations and health decision making: a case study

  Marisa Santos, Anete Trajman, Márcia Pinto

  298-301

  • PDF (Português (Brasil))

• Time-driven Activity-Based Costing (TDABC) in a department of radiology of a hospital from the South of Brazil

  Naíla Daroit, Karen Ruschel, Frederico Tarrago, Ana Paula Etges

  302-307

  • PDF (Português (Brasil))